NexImmune, Inc. (NEXI)
OTCMKTS
· Delayed Price · Currency is USD
0.0990
-0.0410 (-29.29%)
Jan 17, 2025, 4:00 PM EST
NexImmune Market Cap
NexImmune has a market cap or net worth of $138.07 thousand as of January 17, 2025. Its market cap has decreased by -95.91% in one year.
Market Cap
138.07K
Enterprise Value
-2.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 138.07K, a decrease of -99.97%. That is a compound annual growth rate of -87.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 138.07K | -13.95% |
| Dec 31, 2024 | 160.46K | -93.17% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.93B |
| Veradigm | 1.54B |
| SS Innovations International | 1.41B |
| Nika Pharmaceuticals | 603.98M |
| Elite Pharmaceuticals | 525.59M |
| Glass House Brands | 425.75M |
| Northwest Biotherapeutics | 350.49M |
| BioStem Technologies | 261.80M |